drugset / Trial / NCT00921804
Study to Assess the Efficacy, Safety, and Tolerability of AZD8529 in Adult Schizophrenia Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether treatment with daily oral dose of AZD8529 40 mg administered over 28 days is safe, well tolerated and improves main symptoms of schizophrenia in adult schizophrenia patients.
Timeline
- Start
- 2009-06
- Primary completion
- 2010-05
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD8529 | Other / unclassified | 40 mg | Oral |
| Subject | Risperidone | Other / unclassified | 4 mg | Oral |